SRPX Emerges as a Potential Tumor Marker in the Extracellular Vesicles of Glioblastoma.

Ampudia-Mesias, Elisabet; El-Hadad, Samia; Cameron, Charles Scott; Wöhrer, Adelheid; Ströbel, Thomas; Saydam, Nurten; Saydam, Okay

Ampudia-Mesias, Elisabet; El-Hadad, Samia; Cameron, Charles Scott; Wöhrer, Adelheid; Ströbel, Thomas; Saydam, Nurten; Saydam, Okay.

Afiliação

Ampudia-Mesias E; Department of Pediatrics, Division of Hematology and Oncology, Medical School, University of Minnesota, Minneapolis, MN 55454, USA.
El-Hadad S; Department of Reproductive Endocrinology, University Hospital Zurich, 8006 Zurich, Switzerland.
Cameron CS; Department of Pediatrics, Division of Hematology and Oncology, Medical School, University of Minnesota, Minneapolis, MN 55454, USA.
Wöhrer A; Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, A-1090 Vienna, Austria.
Ströbel T; Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, A-1090 Vienna, Austria.
Saydam N; Department of Biochemistry, Molecular Biology, and Biophysics, Medical School, University of Minnesota, Minneapolis, MN 55454, USA.
Saydam O; Department of Pediatrics, Division of Hematology and Oncology, Medical School, University of Minnesota, Minneapolis, MN 55454, USA.

Cancers (Basel) ; 14(8)2022 Apr 14.

Article em En | MEDLINE | ID: mdl-35454889

Palavras-chave

EVs; SRPX; glioblastoma; proteomics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Screening_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google